
Regeneron Post COVID Bolus (NASDAQ:REGN)
iLexx/iStock via Getty Images Regeneron (NASDAQ:REGN) is a biotech pharmaceutical company best known for therapies for diseases of the eye. It also had its revenue greatly enhanced this last year from its COVID therapy. That […]